) is a powerful pro-inflammatory mediator, which is formed from arachidonic acid through 5-lipoxygenase (5-LOX). LTD 4 mediates its effects through two specific cell surface receptors, CysLT 1 R and CysLT 2 R (1) . Colon tumours have an increased expression of CysLT 1 R and it has recently been observed that colon cancer patients with high expression levels of this receptor have poor prognosis (2) . The aim of this study was to investigate the potential role of LTD 4 on the control of non-differentiated intestinal epithelial cell growth using intestinal human Caco-2 cells (HTB37, ATCC) in culture.
Leukotriene D 4 (LTD 4 ) is a powerful pro-inflammatory mediator, which is formed from arachidonic acid through 5-lipoxygenase (5-LOX). LTD 4 mediates its effects through two specific cell surface receptors, CysLT 1 R and CysLT 2 R (1) . Colon tumours have an increased expression of CysLT 1 R and it has recently been observed that colon cancer patients with high expression levels of this receptor have poor prognosis (2) . The aim of this study was to investigate the potential role of LTD 4 on the control of non-differentiated intestinal epithelial cell growth using intestinal human Caco-2 cells (HTB37, ATCC) in culture.
We observed that LTD 4 (1-100 nM) induces Caco-2 cell proliferation in a concentration dependent manner. Moreover, cell growth and DNA synthesis induced by LTD 4 were reverted by specific CysLT 1 R antagonists, such as MK571 and LY171883, thus indicating the involvement of this receptor in these events.
Considering that LTD 4 up-regulates 5-LOX, cyclooxigenase 2 (COX-2) and CysLT 1 R levels in intestinal epithelial cells (3) , we study the role of COX pathway on the effect of LTD 4 on Caco-2 cell growth. Our findings show that LTD 4 induces PGE 2 synthesis in Caco-2 cell cultures. Moreover, ketoprofen, a COX inhibitor, NS398, a specific COX-2 inhibitor, and SC560, a specific COX-1 inhibitor, were able to inhibit Caco-2 cell growth and DNA synthesis induced by LTD 4 . Furthermore, similar effects were obtained using antagonists of PGE 2 receptor, such as SC19220, a specific EP 1 antagonist, and AH23838, a specific EP 4 antagonist.
These data suggest that the proliferative effect of LTD 4 is dependent on PGE 2 synthetized by both COXs and on PGE 2 interaction with EP 1 and EP 4 receptors. Finally, we provide evidence that LTD 4 stimulates several cell signalling pathways involved in cell growth, such as ERK, b-catenin, CREB, and p38a.
On the basis of our results we can conclude that LTD 4 is involved in the regulation of Caco-2 cell growth through the interaction of CysLT 1 R and the subsequent PGE 2 synthesis and cell signaling pathways activation. It is hoped that these findings show novel mechanisms by which the effect of LTD 4 on intestinal epithelial cell growth may be mediated.
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